BOULDER, Colo. -- May 19, 2008 - Miragen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease based ...

This is a preview. Log in through your library . Abstract This paper is devoted to an examination of the discovery, characterization, and analysis of the functions of microRNAs, which also serves as a ...

WEST LAFAYETTE, Ind. — Andrea Kasinski, an assistant professor of biology in Purdue University’s College of Science, has been awarded grants to improve microRNA therapeutics for cancer by the American ...

In a new study published in Journal of the American Chemical Society, Chen-Yu Zhang's group at Nanjing University reports photo-clickable miRNAs as probes for intracellular target identification of ...

Researchers have found that levels of methylated microRNA were significantly higher in tissue and serum from cancer patients compared with that from normal controls. Specifically, methylation levels ...

MicroRNAs Are More Plentiful and More Subtle In Action Than Was Once Suspected One of the unexpected findings of the Human Genome Project was that over 98% of the human genome does not encode for ...

A novel angiogenic microRNA drug can be a new option for the treatment of ischemic cardiovascular disease, according to a new study published in PLOS ONE by researchers from the University of Eastern ...

BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease based ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Regulus Therapeutics Inc. today announced the establishment of a new collaboration with GlaxoSmithKline (GSK) to develop and commercialize microRNA therapeutics ...

A novel angiogenic microRNA drug might be a new option for the treatment of ischemic cardiovascular disease, according to a new study (“Nuclear microRNA-466c regulates Vegfa expression in response to ...

Dr. Pad Chivukula Resigns as Chief Scientific Officer and Chief Operating Officer SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading RNA medicines company ...